• Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue

Eli Lilly’s Lyumjev receives FDA approval

14/09/2021 No Comments

Eli Lilly has received FDA approval and expanded labelling for its Lyumjev rapid-acting insulin. Lyumjev is a novel formulation of insulin lispro for speeding up

Read More ยป

Follow us elsewhere

Facebook Twitter Instagram

Latest tweets

Recent posts

FDA approves cellular therapy for patients with Type 1 diabetes

CellTrans wins FDA approval for first cell therapy that treats Type 1 diabetes

Beta Bionics $100m to challenge for automated insulin dosing market

  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Site by Loopmill